![infographic icon](https://clinical.catalent.com/wp-content/uploads/sites/5/2020/05/infographic.png)
Direct-to-Patient Supply: Industry Perception and Future Trends
Summary: Catalent and Fierce Pharma surveyed 234 individuals involved in clinical supply and clinical operations to better understand the industry perception around importance of having a direct-to-patient option for the delivery of clinical supplies in both current and future studies, including perceived benefits and potential barriers to its use.